The project is currently under development, with an estimated total project cost of approximately ₹100 Crore, with oncology services targeted for launch by 2027.

Donor support will fund critical oncology equipment such as LINAC, PET-CT, MRI, and brachytherapy systems, essential for diagnosis and treatment.

No. Infrastructure is already being funded separately, ensuring that 100% of philanthropic contributions directly support patient-care equipment.

The centre is expected to support 25,000+ consultations annually and provide treatment to approximately 20,000 cancer patients each year.

All equipment will be owned by SughaVazhVu Healthcare (Section 8), ensuring clear asset ownership, accountability, and transparent utilisation.

The project will follow statutory audits, board oversight, and separate accounting, with periodic utilisation and impact updates shared with partners.

The model enables access for government scheme beneficiaries, subsidised patients, and underserved communities, while maintaining sustainability.

Yes. Donors support high-impact equipments such as a LINAC, PET-CT, MRI & Brachytherapy

Yes. Partners are welcome to visit Tiruchirappalli, review progress, and engage with the leadership team.

The centre will serve as a regional oncology hub for 9–10 million people, improving early diagnosis, reducing travel burden, and strengthening cancer care access.

This model combines infrastructure investment with philanthropic equipment support to create a sustainable, institution-led cancer care ecosystem. “Each equipment supported directly contributes to diagnosing and treating thousands of patients annually.”

Email: csr@sughavazhvuhealthcare.co.in ritu@sughavazhvuhealthcare.co.in